ANDERNACH, Germany, April 29, 2026 /PRNewswire/ -- LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company specializing in advanced drug delivery systems, today announced ...
Dublin, April 30, 2026 (GLOBE NEWSWIRE)-- The "Topical Drugs Contract Development and Manufacturing Organization (CDMO) Market Report 2026" has been added to ResearchAndMarkets.com's offering. The ...
Contract manufacturing powerhouse Lonza is growing in more ways than one. | Contract manufacturing powerhouse Lonza is growing in more ways than one. The Swiss company revealed this week that it is ...
While large-molecule therapeutics capture most headlines, small-molecule drugs face significant challenges, struggling with funding cuts, supply chain disruptions, and growing demand. At the same time ...
1.WuXi AppTec‘s integrated CRDMO platform enhances speed and efficiency in drug development by reducing operational handoffs, allowing companies to move therapies from concept to patient delivery more ...
"We have over 100 pre-scheduled meetings. On-site at BIO USA, you can really sense the changing status of K-Bio." This ...
CDMO Sterling plots buyout of antibody-drug conjugate specialist in play at next-gen oncology market
Sterling has been rapidly expanding its U.S. presence, including buying this Cary, North Carolina, site back in 2019. (Sterling Pharma Solutions) (Sterling Pharma Solutions ) A little more than two ...
It’s hard nowadays for any big company to distance itself from artificial intelligence and its subset, machine learning. Drug services firms are no exception. These technologies are slowly picking up ...
LUXEMBOURG--(BUSINESS WIRE)--Eurofins CDMO Alphora Inc. announces that it has received its Health Canada Cannabis Drug License issued within the Cannabis Act and Cannabis Regulations for its Oakville, ...
BioUSA fuels Koreas CDMO race and AI-driven dealmaking Korean pharma and biotech court partners at San Diego mega meet as U.S ...
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Eurofins CDMO announces the strategic expansion of its existing Drug Product operation capabilities with the early 2020 completion of its new Drug Product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results